Gevorg Yaghjyan/LinkedIn
Apr 9, 2026, 14:46
Gevorg Yaghjyan: Advancing Research and Care for Transketolase Deficiency at Yale
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
”New rare-disease research and clinical program has recently been launched at the Yale School of Medicine focusing on Transketolase (TKT) deficiency, an extremely rare genetic metabolic disorder.
The Yale Transketolase Deficiency Program was established to:
- Improve diagnosis of patients with this rare disorder
- Conduct cutting-edge research on the disease mechanism
- Develop future therapeutic strategies
- Provide multidisciplinary clinical care for patients with suspected or confirmed disease
The program is led by physicians and researchers including Andrew Wang and Anna Szekely at Yale.
It collaborates with major rare-disease networks such as:
the Undiagnosed Diseases Network
the National Organization for Rare Disorders (NORD)
to identify additional patients worldwide and accelerate research”
Stay updated with Hemostasis Today.
-
May 10, 2026, 16:20Joshua Ngimbwa: How Sex and Socioeconomic Factors Influence Stroke Outcomes in Tanzania
-
May 10, 2026, 16:18Gustavo Monnerat: How Thousands of Fake References Slipped Into Biomedical Literature
-
May 10, 2026, 16:13Dalius Jatužis: Our AI-Driven Automated Stroke Registry Data Extraction Gets Best Poster Award at ESOC 2026
-
May 10, 2026, 16:11Full House for Breakfast with the Experts – American Society for Apheresis
-
May 10, 2026, 15:59Luma Mahairi: AI and Digital Hematology Are Transforming Emergency Laboratory Care in 2026
-
May 10, 2026, 15:55Reza Shojaei: Designing Blood Systems for Chronic Demand
-
May 10, 2026, 15:52Alan Nurden: How Platelets Construct a Thrombus Under Flow
-
May 10, 2026, 15:36Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
-
May 10, 2026, 15:33Abdul Mannan: Here’s when Your POC INR Machine Misleads You